Hipolixan 600 / 900

Array
(
    [ID] => 1225
    [post_author] => 16
    [post_date] => 2012-06-18 19:27:34
    [post_date_gmt] => 2012-06-18 19:27:34
    [post_content] => 
Forma farmacéutica:
Comprimidos Recubiertos
Composición:
Cada comprimido recubierto contiene:

Hipolixan 600: Gemfibrozil 600 mg
Hipolixan 900: Gemfibrozil 900 mg
Acción Terapéutica:
Hipolipemiante. Hipocolesterolemizante.
Indicaciones:
Hipercolesterolemia, dislipidemia combinada e hipertrigliceridemia (tipos IIa, IIb y IV respectivamente de la clasificación de Fredrickson).
Dislipidemias tipos III y V de Fredrickson; asociadas con diabetes; asociada con xantomatosis.
Niveles elevados de triglicéridos séricos (hiperlipidemia tipos IV y V) que presentan riesgo de pancreatitis.
Prevención primaria de la enfermedad coronaria e infarto agudo de miocardio.
Presentaciones:
Hipolixan 600: Envases por 30 comprimidos recubiertos.
Hipolixan 900: Envases por 30 comprimidos recubiertos.
    [post_title] => Hipolixan 600 / 900
    [post_excerpt] => Hipolipemiante. Hipocolesterolemizante.
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => hipolixan-600-900
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2020-11-24 12:59:20
    [post_modified_gmt] => 2020-11-24 15:59:20
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://www.bago.com.ar/vademecum//?post_type=productos&p=1225
    [menu_order] => 0
    [post_type] => productos
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
    [prospecto_para_pacientes] => Array
        (
        )

    [url_para_mayor_informacion_video] => 
    [url_para_mayor_informacion] => 
    [url_productos_consumo_masivo] => 
    [prospecto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 1226
                    [post_author] => 16
                    [post_date] => 2012-06-18 19:27:10
                    [post_date_gmt] => 2012-06-18 19:27:10
                    [post_content] => 
                    [post_title] => hipolixan_600_900_cpr_pp_apr_anmat_disp_0027.pdf
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => open
                    [post_password] => 
                    [post_name] => hipolixan_600_900_cpr_pp_apr_anmat_disp_0027-pdf
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2012-06-18 19:27:10
                    [post_modified_gmt] => 2012-06-18 19:27:10
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => 
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [presentacion_img] => Array
        (
        )

    [logo_img] => Array
        (
        )

    [foto_producto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 13317
                    [post_author] => 16
                    [post_date] => 2017-07-25 15:03:23
                    [post_date_gmt] => 2017-07-25 18:03:23
                    [post_content] => 
                    [post_title] => hipolixan
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => hipolixan
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2017-07-25 15:03:23
                    [post_modified_gmt] => 2017-07-25 18:03:23
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2017/07/hipolixan.png
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/png
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [fotos_lanzamiento] => Array
        (
        )

    [especialidad] => Array
        (
        )

    [marca] => Array
        (
            [0] => Hipolixan
        )

    [principio_activo] => Array
        (
            [0] => Gemfibrozil
        )

    [post_content_formatted] => 
Forma farmacéutica:
Comprimidos Recubiertos
Composición:
Cada comprimido recubierto contiene:
Hipolixan 600: Gemfibrozil 600 mg

Hipolixan 900: Gemfibrozil 900 mg
Acción Terapéutica:
Hipolipemiante. Hipocolesterolemizante.
Indicaciones:
Hipercolesterolemia, dislipidemia combinada e hipertrigliceridemia (tipos IIa, IIb y IV respectivamente de la clasificación de Fredrickson).

Dislipidemias tipos III y V de Fredrickson; asociadas con diabetes; asociada con xantomatosis.

Niveles elevados de triglicéridos séricos (hiperlipidemia tipos IV y V) que presentan riesgo de pancreatitis.

Prevención primaria de la enfermedad coronaria e infarto agudo de miocardio.
Presentaciones:
Hipolixan 600: Envases por 30 comprimidos recubiertos.

Hipolixan 900: Envases por 30 comprimidos recubiertos.

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/hipolixan_600_900_cpr_pp_apr_anmat_disp_0027.pdf
        )

)

anexo_congre_single